Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02216838 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Facial Flushing With Botulinum Toxin A Injections

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2027v16
  2. Phase: Not applicable to Phase 4
    • Primary and study completion dates: Dec 2024 to Dec 2025
    v15
  3. Primary and study completion dates: Dec 2023 to Dec 2024v14
  4. Primary and study completion dates: Dec 2022 to Dec 2023v13
  5. Primary and study completion dates: Dec 2021 to Dec 2022v12
Show 10 earlier versionsHide 10 earlier versions
  1. Re-verified, no change to tracked fieldsv11
  2. Primary and study completion dates: Dec 2020 to Dec 2021v10
  3. Primary and study completion dates: Dec 2019 to Dec 2020v9
  4. Primary and study completion dates: Dec 2018 to Dec 2019v8
  5. Primary and study completion dates: Dec 2017 to Dec 2018v7
  6. Primary completion date: Dec 2016 to Dec 2017v6 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 20 to confirmed 16
    • Study completion date: Jul 2017 to Dec 2017
    • Site details revised
  7. Primary completion date: Aug 2016 to Dec 2016v5
  8. Primary completion date: Jul 2016 to Aug 2016
    • Site contact updated
    v4
  9. Primary completion date: Jul 2015 to Jul 2016
    • Study completion date: Jul 2015 to Jul 2017
    v3
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat facial flushing. This study is a pilot study designed to determine feasibility of these procedures.
Trial Details
NCT Number NCT02216838
Lead Sponsor Northwestern University
Conditions
(from sponsor)		 Facial Flushing
Related terms Blushing
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov